A european multicentre and open-label controlled randomized trial to evaluate the efficacy of sequential treatment with TAcrolimus-Rituximab versus steroids plus cyclophosphamide in patients with primary MEmbranous Nephropathy: The STARMEN study

  1. Rojas-Rivera, J.
  2. Fernández-Juárez, G.
  3. Ortiz, A.
  4. Hofstra, J.
  5. Gesualdo, L.
  6. Tesar, V.
  7. Wetzels, J.
  8. Segarra, A.
  9. Egido, J.
  10. Praga, M.
Aldizkaria:
Clinical Kidney Journal

ISSN: 2048-8513 2048-8505

Argitalpen urtea: 2015

Alea: 8

Zenbakia: 5

Orrialdeak: 503-510

Mota: Artikulua

DOI: 10.1093/CKJ/SFV075 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak